Iran is a leader in Phase III clinical trials in women’s health
Iran’s dominance in women’s health is spread comprehensively across indications, with more clinical trials than any other country.
By
CW and RW
Latest in
CW and RW
Karuna’s KarXT shows promise for schizophrenia treatment
Continued trial success for KarXT could give it a major competitive edge over current atypical antipsychotics for schizophrenia.
By
Myovant & Pfizer’s MyFembree receives nod from the FDA for endometriosis
GlobalData expects MyFembree, a combination therapy developed by Myovant and Pfizer, to be successful in the endometriosis space.
By
Novel checkpoint inhibitors hit by another setback, but opportunities remain
A trial of novel checkpoint inhibitor monalizumab has been terminated after the drug failed to meet the efficacy threshold.
By
Top tweets: Reductions in dietary fat alter brain reward circuitry – and more
Clinical Trials Arena lists five of the top tweets on metabolic disorders in Q2 2022 based on data from GlobalData’s…
Findings suggest urban-rural divide in early-onset dementia diagnosis
The geographic disparities behind early-onset dementia highlight the need to bridge the urban-rural divide.
By
Monkeypox outbreak poses increased risk for 417,000 men who have sex with men
Concern over the monkeypox virus is higher among men who have sex with men (MSM) due to the nature of…
By
The NHS acts to tackle the gender health gap in the UK
A strategy proposed by the DHSC sets bold ambitions to tackle deep-rooted, systemic issues within the UK’s healthcare system.
By